Comparable clinical outcomes with same-day versus rapid initiation of antiretroviral therapy in Taiwan

YI-CHIA HUANGYang, Chia-JuiChia-JuiYangHSIN-YUN SUNLee, Chen-HsiangChen-HsiangLeeLu, Po-LiangPo-LiangLuTang, Hung-JenHung-JenTangLiu, Chun-EngChun-EngLiuLee, Yuan-TiYuan-TiLeeTsai, Chin-ShiangChin-ShiangTsaiLee, Nan-YaoNan-YaoLeeLiou, Bo-HuangBo-HuangLiouHung, Tung-CheTung-CheHungLee, Mei-HuiMei-HuiLeeHuang, Miao-HuiMiao-HuiHuangWang, Ning-ChiNing-ChiWangLin, Chi-YingChi-YingLinLee, Yi-ChienYi-ChienLeeCheng, Shu-HsingShu-HsingChengCHIEN-CHING HUNG2024-03-062024-03-062024-0312019712https://scholars.lib.ntu.edu.tw/handle/123456789/640422WHO has recommended same-day antiretroviral therapy (SDART) initiation since 2017; however, higher attrition rates were noted in developing countries.enCare continuum; Engagement in care; Test-and-treat; Virologic response[SDGs]SDG3[SDGs]SDG5[SDGs]SDG17Comparable clinical outcomes with same-day versus rapid initiation of antiretroviral therapy in Taiwanjournal article10.1016/j.ijid.2023.12.012381636182-s2.0-85182549275https://api.elsevier.com/content/abstract/scopus_id/85182549275